KCM
JNJ icon

Kathmere Capital Management’s Johnson & Johnson JNJ Stock Holding History

Kathmere Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
46,204
+2,396
+5% +$558K 0.62% 34
2026
Q1 		$10.7M Buy
43,808
+4,272
+11% +$995K 0.66% 34
2025
Q4 		$8.18M Buy
39,536
+3,070
+8% +$607K 0.55% 37
2025
Q3 		$6.76M Buy
36,466
+4,198
+13% +$719K 0.48% 42
2025
Q2 		$4.93M Sell
32,268
-872
-3% -$134K 0.38% 54
2025
Q1 		$5.5M Buy
33,140
+10,443
+46% +$1.63M 0.47% 45
2024
Q4 		$3.28M Sell
22,697
-1,919
-8% -$297K 0.29% 61
2024
Q3 		$3.99M Buy
24,616
+9,332
+61% +$1.49M 0.37% 48
2024
Q2 		$2.23M Sell
15,284
-33
-0.2% -$4.91K 0.24% 67
2024
Q1 		$2.42M Buy
15,317
+2,711
+22% +$432K 0.28% 60
2023
Q4 		$1.98M Sell
12,606
-3,259
-21% -$500K 0.26% 58
2023
Q3 		$2.47M Buy
15,865
+2,623
+20% +$433K 0.37% 51
2023
Q2 		$2.19M Buy
13,242
+195
+1% +$31.5K 0.34% 50
2023
Q1 		$2.02M Sell
13,047
-5,123
-28% -$827K 0.33% 51
2022
Q4 		$3.21M Buy
18,170
+8,166
+82% +$1.41M 0.57% 39
2022
Q3 		$1.63M Sell
10,004
-2,104
-17% -$356K 0.33% 51
2022
Q2 		$2.15M Buy
12,108
+1,428
+13% +$254K 0.4% 40
2022
Q1 		$1.89M Buy
10,680
+5,694
+114% +$969K 0.32% 39
2021
Q4 		$853K Sell
4,986
-1,276
-20% -$209K 0.15% 57
2021
Q3 		$1.01M Buy
6,262
+1,074
+21% +$183K 0.18% 48
2021
Q2 		$855K Buy
5,188
+644
+14% +$107K 0.16% 56
2021
Q1 		$747K Buy
4,544
+318
+8% +$51.5K 0.15% 59
2020
Q4 		$665K Buy
4,226
+20
+0.5% +$2.95K 0.14% 53
2020
Q3 		$626K Buy
4,206
+1,676
+66% +$248K 0.16% 47
2020
Q2 		$356K Sell
2,530
-1,339
-35% -$195K 0.1% 70
2020
Q1 		$507K Buy
3,869
+448
+13% +$63.6K 0.18% 53
2019
Q4 		$499K Buy
+3,421
New +$464K 0.18% 61

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Kathmere Capital Management's JNJ Position: Q2 2026 in Review

Kathmere Capital Management increased its Johnson & Johnson (JNJ) stake by 5.5% in Q2 2026, buying an estimated $558K and bringing the position to 46,204 shares worth $11.7M. The position accounts for 0.62% of the portfolio, ranked #34.

Kathmere Capital Management first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kathmere Capital Management held 46,204 shares of Johnson & Johnson worth $11.7M as of Q2 2026.
  • Kathmere Capital Management bought 2,396 Johnson & Johnson shares in Q2 2026, an estimated $558K.
  • Johnson & Johnson made up 0.62% of Kathmere Capital Management's portfolio in Q2 2026, its #34 holding.
  • Kathmere Capital Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.